Amir Landi

Abdolamir Landi, also known as, Amir Landi, MD, PhD, is a senior research scientist and principal investigator in the Department of Medical Microbiology and Immunology at the University of Alberta, Canada. He is a member of the ME/CFS committee of the Alberta Medical Association and a Research and Medical Advisor to National ME/FM Action Network, Canada. He has been working on the immunologic aspects of ME/CFS since 2010.

Dr. Landi leads the biomarker team in Professor Michael Houghton's laboratory in the Department of Medical Microbiology and Immunology at the University of Alberta, Canada, working to validate a panel of cytokine biomarkers for ME/CFS.

Education

 * 1995, MD - Tehran University of Medical Sciences, Iran
 * 2009, PhD - focused on Immunovirology / Vaccinology from University of Saskatchewan, Canada
 * 2010, post doctorate fellowship - Vaccine and Infectious Disease Organization, International Vaccine Centre, Saskatoon, Saskatchewan, Canada

Research studies

 * 2011, No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome (Full text)
 * 2016, Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome (Full text)

Talks and interviews

 * 27-30 May 2015, London, UK, Biomedical Research into ME Colloquium (BRMEC5) - Speech title: Cytokine and Chemokine Profiles of ME/CFS Patients.
 * 3-5 May 2018, Montreal, Canada, ME/CFS Canadian Collaborative Team Conference - Speech title: Diagnosis of ME/CFS: Can Immune Modulators Play a Role?
 * 14 & 15 Dec. 2018, Montreal, Canada CIHR ME/CFS Strengthening Workshop - Speech title: Immunobiology of ME/CFS: “From pathogen discovery to pathogenesis.

Online presence

 * LinkedIn


 * ResearchGate